AstraZeneca Settlement Has Consumer Class Split
U.S. consumers who agreed to a $24 million settlement with AstraZeneca in a long-running battle with pharmaceutical companies over wholesale drug prices are now fighting one of their own, who has...To view the full article, register now.
Already a subscriber? Click here to view full article